ToxBlox

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameToxBlox
Drug Alias Namedominant negative inhibitor therapy (PharmAthene)anthrax therapy (PharmAthene)DNI therapy (PharmAthene)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAnthrax protective antigen modulators
TargetsAnthrax protective antigen
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmathene IncHarvard University
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A